Clinical Data From Phase II Study in Early Breast Cancer Suggests Potential Use of Herceptin With Navelbine as reported at the annual meeting of the American Society of Clinical Oncology (ASCO)

Second study presented at ASCO demonstrates that patients with HER-2 metastatic breast cancer can respond to treatment with Herceptin REGARDLESS of their estrogen receptor (ER) status.

Navelbine and herceptin for early BC
 

My mom is 72 yrs old diagnosed with BC that is stage IIA that is HER pos and was given only navelbine and herceptin for 12 weeks and herceptin for a full year every three weeks. Her Oncologist recommended this treatment given her age and medical conditions. She will complete a year of heceptin in nov 2007. If you have any information on this treatment combination please refer me to it.

thanks

Haidar